cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
cbdMD announced it will host a conference call on August 13, 2026, at 4:20 p.m. ET to discuss its third quarter financial results for the period ended June 30, 2026.
The call will cover business progress and financial performance; interested parties can access the event via a live webcast or by dialing in.
Ronan Kennedy, the company's CEO and CFO, is listed as the primary contact for investor inquiries.